10.1080/17415993.2012.703671
The research explores the development of new antimicrobial compounds. The study aims to address the increasing resistance of bacteria and fungi to existing antimicrobial agents by synthesizing and evaluating the antimicrobial activity of novel spiroisoxazolo[2,3-b][1,2,4]thiadiazole-2,2′-thiazolidine-4′-ones (9a–9e) and spiroisoxazolo[2,3-b][1,2,4]oxadiazole-2,2′-thiazolidine-4′-ones (12a–12e). The synthesis involved key chemicals such as 3-amino-5-methylisoxazole, aryl isothiocyanates, aryl isocyanates, and mercaptoacetic acid. The compounds were tested for their antibacterial and antifungal activities against various bacterial and fungal strains, showing significant antimicrobial activity compared to standard drugs like Cipro?oxacin and Clotrimazole. The study concludes that these novel compounds, featuring isoxazole–thiadiazole–thiazolidone and isoxazole–oxadiazole–thiazolidone ring systems, have promising potential as new antimicrobial agents, particularly those with specific substituents on the benzene ring, such as chloro, methoxy, and bromo groups.